Melanoma Clinical Trials

A listing of Melanoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 747 clinical trials
None
Dendritic Cells Plus Autologous Tumor RNA in Uveal Melanoma

Patients suffering from uveal melanoma (typed positive for monosomy 3 and without evidence for metastases) will be vaccinated over a period of 2 years with Dendritic Cell loaded with autologous

metastasis
therapeutic autologous dendritic cells
  • 20 views
  • 09 May, 2021
  • 12 locations
None
Nivolumab Plus Relatlimab in Patients With Metastatic Uveal Melanoma

The purpose of this research is to test if a combination treatment of nivolumab and relatlimab will result in tumor reduction in patients with metastatic uveal melanoma.

  • 0 views
  • 09 Jan, 2022
  • 2 locations
None
Adoptive Tumor-infiltrating Lymphocyte Transfer With Nivolumab for Melanoma

with metastatic melanoma that failed immunotherapy.Tumor-infiltrating lymphocytes will be expanded from resected melanoma samples from the patient and expanded TILs will be transferred to the patient

gilbert's syndrome
hepatitis b antigen
metastatic melanoma
neutrophil count
cyclophosphamide
  • 0 views
  • 14 Aug, 2021
  • 1 location
None
FHD-286 in Subjects With Metastatic Uveal Melanoma

activity of FHD-286 oral monotherapy in subjects with metastatic Uveal Melanoma (UM).

  • 0 views
  • 27 Oct, 2021
  • 9 locations
None
Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma

This research study is investigating Binimetinib and Belinostat in participants with metastatic uveal melanoma. The research study will test the study drugs to see if the combination of

  • 0 views
  • 04 Jan, 2022
  • 1 location
None
FLX475 in Combination With Ipilimumab in Advanced Melanoma

This clinical trial is a Phase 2, open-label study to determine the anti-tumor activity of FLX475 in combination with ipilimumab in subjects with advanced melanoma previously treated with an

  • 0 views
  • 22 Sep, 2021
  • 4 locations
None
ECT-Pembrolizumab in Patients With Unresectable Melanoma With Superficial or Superficial and Visceral Metastases

This is a Phase 2 multicenter, open label, non-randomized, interventional study enrolling 53 patients.The objectives and purposes of the clinical study described herein are to determine if concomitant Pembrolizumab (Keytruda) and ECT treatments are safe and able to improve local and systemic response rates.ECT will be performed with the CLINIPORATOR …

unresectable melanoma
metastasis
measurable disease
brain metastases
pembrolizumab
  • 6 views
  • 10 Nov, 2021
  • 1 location
None
ImmPACT Expanded Multiple Antigen Specific Endogenously Derived T Cells (MASE-T) to Patients With Metastatic Melanoma

With the introduction of checkpoint inhibitors substantial improvements have been made in the treatment of malignant melanoma (MM). Despite this still a a subset of patients, approximately 50

pembrolizumab
cytotoxic t-lymphocyte antigen 4
metastatic melanoma
neutrophil count
cyclophosphamide
  • 0 views
  • 25 Sep, 2021
  • 1 location
None
Adjuvant Nivolumab Treatment in Stage II (IIA, IIB, IIC) High-risk Melanoma

. However, to subdivide stage II melanoma patients into having a low or high risk for relapse further methods are needed. This clinical trial will evaluate whether adjuvant nivolumab treatment will

  • 9 views
  • 21 Dec, 2021
  • 37 locations
None
Multicenter Phase 1b Trial Testing the Neoadjuvant Combination of Domatinostat Nivolumab and Ipilimumab in IFN-gamma Signature-low and IFN-gamma Signature-high RECIST 1.1-measurable Stage III Cutaneous or Unknown Primary Melanoma

+ nivolumab + ipilimumab in IFN-gamma signature low patients with de-novo or recurrent macroscopic stage III cutaneous or unknown primary melanoma. The trial will include 45 stage III cutaneous or

  • 1 views
  • 25 Jan, 2021
  • 1 location